Abstract:Abstract Background Streptococci are the dominant species in the human oral cavity and upper respiratory tract. Oral mucositis affects 30–40% of the patients receiving chemotherapy and 80% undergoing HSCT. During episode of oral mucositis, patients are at a risk for invasive infections caused by opportunistic pathogens in the oral cavity. The purpose of this study was to investigate the clinical characteristics of S. mitis/oralis invasive infection, and find patients at high risk for with S. mitis/oralis infection in order to prevention of S. mitis/oralis bacteremia. Methods Patients receiving chemotherapy or stem cell transplant for malignancies and primary immunodeficiencies at the pediatric bone marrow transplant center of Seoul St. Mary's hospital admitted during January 2017 to December 2020 for blood stream infections were included in this study. Chart review of the patients were done retrospectively. Results During the four year study period, there were 4,647 admissions, and 2,358 (50.7%) experienced at least 1 episode of fever. Overall, the incidence of bacteremia was 10.9% of all febrile children. The most common pathogen causing bacteremia was S. mitis/oralis (24%), followed by E. coli (14.3%), Klebsiella spp. (10.5%), and S. epidermidis (7.4%). Candida sepsis occurred in 3.5% of the children. By year, the proportion of bacteremia caused by S. mitis/oralis was 19% in 2017, 21% in 2018, 41% in 2019, and 25% in 2020. 51% of S. mitis/oralis bacteremia occurred 8-14 days after day 0 of chemotherapy. A multivariate analyses on risk factors for S. mitis/oralis bacteremia was the underlying disease AML (OR, 4.6; 95% CI, 2.4-8.7; P< 0.001), and the use of cytarabine (OR, 4.5; 95% CI, 2.4-8.5; P< 0.001). Compared to ALL, AML has a HR 3.7 (95% CI 1.9-7.2) of bacteremia with S. mitis/oralis. Prolonged duration of fever ( >7 days) was observed in 13.4% of the patients, and a fever duration >14 days was observed in 2 patients. Complications such as septic shock, n=4 (6.0%), ARDS, n=1 (1.5%), infective endocarditis, n=2 (3.0%) were observed. Conclusion S. mitis/oralis sepsis causes significant morbidity in patients undergoing treatment for malignancies. Patients with AML are at the highest risk, especially after induction or consolidation chemotherapy including cytarabine. Disclosures All Authors: No reported disclosures.

Risk of infective endocarditis in Streptococcal mitis bloodstream infections among patients with neutropenia from hematologic malignancies

Infective endocarditis is rare in patients with hematologic malignancy and neutropenia

Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections

Infective endocarditis:a review of 28 cases

Utility of echocardiogram in neutropenic patients with gram positive bacteremia – a retrospective study

Population genomics of Streptococcus mitis in UK and Ireland bloodstream infection and infective endocarditis cases

1860. Streptococcus mitis/oralis sepsis in patients with neutropenia after chemotherapy

Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity

Non-betahemolytic streptococcal bacteremia, cardiac implantable electronic device, endocarditis, extraction, and outcome; a population-based retrospective cohort study

Clinical Features of Bloodstream Infection in Children with Haematological Malignancies

Epidemiology, Resistant Pathogens, and Causes of Early Death in Cases of Bloodstream Infection in Patients with Hematological Malignancies from 2012–2019

Gemella Haemolysans Infective Endocarditis in a Patient With Febrile Neutropenia

Infective endocarditis due to Streptococci and Enterococci: A 3-year retrospective study

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literature

Microbiologically Documented Bloodstream Infection in Children with Malignancies: A Single-center Experience.

Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study

Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.

Emergence of Carbapenem-Resistant Enterobacteriaceae As Causes of Bloodstream Infections in Patients with Hematologic Malignancies

Significant Morbidity and Mortality Attributable to Rothia Mucilaginosa Infections in Children with Hematological Malignancies or Following Hematopoietic Stem Cell Transplantation

Retrospective clinical analysis of 91 adult neutropenic patients with bloodstream infection